Effective Data Sharing as a Conduit for Advancing Medical Product Development

Author:

Karpen Stephen R.,White J. Kael,Mullin Ariana P.,O’Doherty Inish,Hudson Lynn D.,Romero Klaus,Sivakumaran Sudhir,Stephenson Diane,Turner Emily C.,Larkindale JaneORCID

Abstract

Abstract Introduction Patient-level data sharing has the potential to significantly impact the lives of patients by optimizing and improving the medical product development process. In the product development setting, successful data sharing is defined as data sharing that is actionable and facilitates decision making during the development and review of medical products. This often occurs through the creation of new product development tools or methodologies, such as novel clinical trial design and enrichment strategies, predictive pre-clinical and clinical models, clinical trial simulation tools, biomarkers, and clinical outcomes assessments, and more. Methods To be successful, extensive partnerships must be established between all relevant stakeholders, including industry, academia, research institutes and societies, patient-advocacy groups, and governmental agencies, and a neutral third-party convening organization that can provide a pre-competitive space for data sharing to occur. Conclusions Data sharing focused on identified regulatory deliverables that improve the medical product development process encounters significant challenges that are not seen with data sharing aimed at advancing clinical decision making and requires the commitment of all stakeholders. Regulatory data sharing challenges and solutions, as well as multiple examples of previous successful data sharing initiatives are presented and discussed in the context of medical product development.

Funder

U.S. Food and Drug Administration

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Reference40 articles.

1. Bauchner H, Golub RM, Fontanarosa PB. Data sharing: an ethical and scientific imperative. JAMA. 2016;315(12):1238–40.

2. A multi-agent system to support evidence based medicine and clinical decision making via data sharing and data privacy - ScienceDirect. Accessed 2020 July 6. https://www.sciencedirect.com/science/article/pii/S0167923616300811

3. Advances in Sharing Multi-sourced Health Data on Decision Support Science 2016–2017. Accessed 2020 July 6. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115214/

4. CURE ID [Internet]. Accessed 2020 Dec 6. https://cure.ncats.io/sign-in

5. Fogel DB. Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review. Contemp Clin Trials Commun. 2018;7(11):156–64.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3